Mark: other references

2023-10-01T20:27:41Z

other references

← Older revision		Revision as of 20:27, 1 October 2023
Line 2:		Line 2:

	==Positive==		==Positive==
	*[[Mantle cell lymphoma]]		*Lymphomas:
	*[[Merkel cell carcinoma]]<ref name=pmid36745184>{{cite journal \|vauthors=Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP \|title=SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma \|journal=Arch Pathol Lab Med \|volume=147 \|issue=7 \|pages=758–766 \|date=July 2023 \|pmid=36745184 \|doi=10.5858/arpa.2022-0238-OA \|ur=}}		**[[Mantle cell lymphoma]]<ref name=pmid17934069>{{cite journal \|vauthors=Ek S, Dictor M, Jerkeman M, Jirström K, Borrebaeck CA \|title=Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma \|journal=Blood \|volume=111 \|issue=2 \|pages=800–5 \|date=January 2008 \|pmid=17934069 \|doi=10.1182/blood-2007-06-093401 \|url=}}</ref> (prognostic significance initially described in <ref name=pmid18729857>{{cite journal \|vauthors=Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, Sander B \|title=The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival \|journal=Br J Haematol \|volume=143 \|issue=2 \|pages=248–52 \|date=October 2008 \|pmid=18729857 \|doi=10.1111/j.1365-2141.2008.07329.x \|url=}}</ref> not borne out by subsequent studies)
			**[[Burkitt's lymphoma]]<ref name=pmid19880779>{{cite journal \|vauthors=Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadström T, Borrebaeck C \|title=Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma \|journal=Haematologica \|volume=94 \|issue=11 \|pages=1563–8 \|date=November 2009 \|pmid=19880779 \|pmc=2770967 \|doi=10.3324/haematol.2009.008474 \|url=}}</ref>
			**[[Lymphoblastic lymphoma]]<ref name=pmid19880779></ref>
			*[[Merkel cell carcinoma]]<ref name=pmid36745184>{{cite journal \|vauthors=Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP \|title=SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma \|journal=Arch Pathol Lab Med \|volume=147 \|issue=7 \|pages=758–766 \|date=July 2023 \|pmid=36745184 \|doi=10.5858/arpa.2022-0238-OA \|ur=}}</ref>

	==References==		==References==

Mark: Starter

2023-10-01T20:20:02Z

Starter

New page

'''SOX11''' [[immunostain]].

==Positive==
*[[Mantle cell lymphoma]]
*[[Merkel cell carcinoma]]<ref name=pmid36745184>{{cite journal |vauthors=Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP |title=SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma |journal=Arch Pathol Lab Med |volume=147 |issue=7 |pages=758–766 |date=July 2023 |pmid=36745184 |doi=10.5858/arpa.2022-0238-OA |ur=}}

==References==
{{Reflist|1}}

[[Category:Immunohistochemistry]]

SOX11 - Revision history

Mark: other references

Mark: Starter